2017 American Transplant Congress
Simultaneous or Sequential Heart-Liver Transplantation Confer Superior Survival in Patients with Listed for Heart-Liver Transplantation: A National Analysis.
1Duke School of Medicine, Durham, NC; 2Dept of Surgery, Duke University Medical Center, Durham, NC
Background: Simultaneous heart-liver transplantation (TXP), for patients with combined heart and liver failure, confers survival benefit over remaining on the waitlist. Whether heart TXP followed…2017 American Transplant Congress
Five Year Outcomes with Alemtuzumab Induction Therapy in Elderly Renal Transplant Recipients.
Pharmacy, Northwestern Memorial Hospital, Chicago, IL
Background:The elderly population (≥ 65 years) comprise one fourth of patients on the waiting list for renal transplantation. Alemtuzumab use has increased over the past…2017 American Transplant Congress
Down but Not Out: Leucopenia Can Be Safely Treated with Reduction in Immunosuppression without Increasing Risk to the Kidney Allograft.
IntroductionLeucopenia is a growing problem with increasing immunosuppression (IS) in kidney transplantation. Reducing IS in the face of leucopenia is a concern due to the…2017 American Transplant Congress
Transplant without Borders – A New Project for Decentralization of Transplant Centers in Brazil.
Organ Transplantation, Bandeirantes Hospital, Sao Paulo, Brazil
The regional disparity in transplant activity is one of the main problems in Brazil and in other countries. Brazilian transplant centers are concentrated in the…2017 American Transplant Congress
Single Kidney Transplantation from Pediatric Donors Younger Than 3 Years to Adult Recipients.
Tongji Hospital,Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
Background: Traditionally, the criteria of splitting pediatric en bloc kidneys for transplantation into two adults includes: donor age > 3 years, donor weight > 12kg,…2017 American Transplant Congress
Graft Survival in De Novo Donor-Specific Antibodies and Positive Flow Crossmatch Kidney Transplants Is influenced by Class I and Class II.
Patients with de novo donor-specific antibodies (dnDSA) show inferior graft survival in numerous small studies. We assessed the effect of dnDSA on graft and patient…2017 American Transplant Congress
When Does the Learning Curve End? A High-Volume Single Center Experience with Laparoscopic Donor Nephrectomy Over 16 Years.
Purpose: No studies for any type of surgery have examined learning curves beyond a decade or 100 cases because surgeon turnover and lack of complete…2017 American Transplant Congress
Achieving Ideal Outcome After Intestinal Transplantation: How Close Are We?
Aim:To determine the incidence of factors affecting ideal outcome after pediatric intestinal transplantation (ITx).Methods: Children that underwent primary ITx with intact grafts at one year…2017 American Transplant Congress
Adjuvant Chemotherapy with Gemcitabine Plus Cisplatin for Kidney Transplant Patients with Transitional Cell Carcinoma.
Urology, Beijing Friendship Hospital, Beijing, China
Background: The purpose of this study was to evaluate the effects and safety of adjuvant chemotherapy with gemcitabine plus cisplatin in kidney transplant patients with…2017 American Transplant Congress
Pre-OLT CKD-3 Increases Post-OLT ESRD and AKI Impacts Early Post-OLT Survival.
Recanati Miller Transplant Institute, Icahn School of Medicine at Mount Sinai, Irvington, NY
Current combined Liver-kidney allocation protocols allocate dual organs based on sustained glomerular filtration rates (eGFR) of 30ml/min or less. It is unclear whether milder renal…
- « Previous Page
- 1
- …
- 44
- 45
- 46
- 47
- 48
- …
- 66
- Next Page »